Clinical Trial Information A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis Protocol Number: 16822 Status: Open Age Group: Adult Treatment Type: Treatment Phase: III NCT ID: NCT06025578 Scope Information Scope: National Disease Site(s): Other